SCHEMBL5455863

SCHEMBL5455863

CCOc1ccccc1NC(=O)Nc1ccc(N2CCNCC2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.62
NPC1 O15118 4/20 0.62
MEN1 O00255 3/20 0.62
LMNA P02545 3/20 0.62
ALDH1A1 P00352 3/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
P2RY1 P47900 1/20 0.61
MAPT P10636 6/20 0.59
RAB9A P51151 3/20 0.59
CASP3 P42574 1/20 0.55
SENP8 Q96LD8 1/20 0.55
SENP7 Q9BQF6 1/20 0.55
SENP6 Q9GZR1 1/20 0.55
KDM4E B2RXH2 1/20 0.55
MAPK1 P28482 1/20 0.55
CA12 O43570 1/20 0.55
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
CA9 Q16790 1/20 0.55
PABPC1 P11940 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5460083 0.87 RAB9A (0.77) KMT2ANPC1MEN1LMNAALDH1A1
SCHEMBL5455937 0.87 MAPT (0.52) KMT2ANPC1MEN1LMNAALDH1A1
SCHEMBL5458428 0.86 MAPT (0.57) KMT2ANPC1MEN1LMNAALDH1A1
SCHEMBL5466937 0.86 KMT2A (0.60) KMT2ANPC1MEN1LMNAALDH1A1
SCHEMBL5465117 0.86 KMT2A (0.61) KMT2ANPC1MEN1LMNAALDH1A1
SCHEMBL5473080 0.85 SMN1; SMN2 (0.55) KMT2ANPC1MEN1LMNAALDH1A1
SCHEMBL5464818 0.84 HTT (0.59) KMT2ANPC1MEN1ALDH1A1SMN1; SMN2
SCHEMBL5462780 0.83 MAPT (0.62) KMT2ANPC1MEN1LMNAALDH1A1
SCHEMBL5460460 0.82 KMT2A (0.60) KMT2ANPC1MEN1LMNAALDH1A1
SCHEMBL5469288 0.82 P2RY1 (0.59) NPC1P2RY1MAPTRAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed
EP-1764360-A1 UREA DERIVATIVE Sankyo Company, Limited (JP) 2007-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 KMT2A 1350/4885NPC1 1089/4885MEN1 1828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.